Table 5.
Summary of the Effects of Low/Intermittent Doses of Naltrexone on Postnatal Development of the Rat Brain when Administered Directly
| Reference | Daily Dose (mg/kg) | Route of Admin. | Duration of Drug Exposure | Age of Offspring when Evaluated (days) | Developmental Effects (Compared to Controls) |
|---|---|---|---|---|---|
| [423] | 1 | s.c. | Birth until 21 days postnatal | 21 | Decreased brain wet weight. |
| [425] | 0.1, 1 or 9 | s.c. | Birth until 21 days postnatal | 21 | Decreased brain wet weight. |
| [428] | 1 | s.c. | Birth until 21 days postnatal | 21 | Decreased brain wet & dry weights. |
| [429] | 1 | s.c. | Birth until 21 days postnatal | 21 |
Increase in cell density, with decreased macroscopic area of hippocampus. Decreased cerebral area & width. |
| [430] | 1 | s.c. | Birth until 21 days postnatal | 21 | Decreases in cerebellar surface dimensions & density of internal granule cells. |
| [431] | 1 | s.c. | Once on postnatal day 6 | 6 | Decreased proliferation (labeling index) in cerebellum. |
| [134] | 1 | s.c. | Birth until 10 or 21 days postnatal | 10 or 21 | Subnormal dendrite length & spine growth, predominant by day 21. |
Admin. = administration, s.c. = subcutaneous, and i.p. = intraperitoneal.